241 related articles for article (PubMed ID: 33166319)
1. PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort.
Small AM; Huffman JE; Klarin D; Lynch JA; Assimes T; DuVall S; Sun YV; Shere L; Natarajan P; Gaziano M; Rader DJ; Wilson PWF; Tsao PS; Chang KM; Cho K; O'Donnell CJ; Casas JP; Damrauer SM;
PLoS One; 2020; 15(11):e0239752. PubMed ID: 33166319
[TBL] [Abstract][Full Text] [Related]
2. Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study.
Cupido AJ; Reeskamp LF; Hingorani AD; Finan C; Asselbergs FW; Hovingh GK; Schmidt AF
JAMA Cardiol; 2022 Sep; 7(9):955-964. PubMed ID: 35921096
[TBL] [Abstract][Full Text] [Related]
3. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.
Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW;
Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831
[TBL] [Abstract][Full Text] [Related]
4. PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients.
Shyamala N; Gundapaneni KK; Galimudi RK; Tupurani MA; Padala C; Puranam K; Kupsal K; Kummari R; Gantala SR; Nallamala KR; Sahu SK; Hanumanth SR
J Gene Med; 2021 Aug; 23(8):e3346. PubMed ID: 33885177
[TBL] [Abstract][Full Text] [Related]
5. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.
Schmidt AF; Swerdlow DI; Holmes MV; Patel RS; Fairhurst-Hunter Z; Lyall DM; Hartwig FP; Horta BL; Hyppönen E; Power C; Moldovan M; van Iperen E; Hovingh GK; Demuth I; Norman K; Steinhagen-Thiessen E; Demuth J; Bertram L; Liu T; Coassin S; Willeit J; Kiechl S; Willeit K; Mason D; Wright J; Morris R; Wanamethee G; Whincup P; Ben-Shlomo Y; McLachlan S; Price JF; Kivimaki M; Welch C; Sanchez-Galvez A; Marques-Vidal P; Nicolaides A; Panayiotou AG; Onland-Moret NC; van der Schouw YT; Matullo G; Fiorito G; Guarrera S; Sacerdote C; Wareham NJ; Langenberg C; Scott R; Luan J; Bobak M; Malyutina S; Pająk A; Kubinova R; Tamosiunas A; Pikhart H; Husemoen LL; Grarup N; Pedersen O; Hansen T; Linneberg A; Simonsen KS; Cooper J; Humphries SE; Brilliant M; Kitchner T; Hakonarson H; Carrell DS; McCarty CA; Kirchner HL; Larson EB; Crosslin DR; de Andrade M; Roden DM; Denny JC; Carty C; Hancock S; Attia J; Holliday E; O'Donnell M; Yusuf S; Chong M; Pare G; van der Harst P; Said MA; Eppinga RN; Verweij N; Snieder H; ; Christen T; Mook-Kanamori DO; Gustafsson S; Lind L; Ingelsson E; Pazoki R; Franco O; Hofman A; Uitterlinden A; Dehghan A; Teumer A; Baumeister S; Dörr M; Lerch MM; Völker U; Völzke H; Ward J; Pell JP; Smith DJ; Meade T; Maitland-van der Zee AH; Baranova EV; Young R; Ford I; Campbell A; Padmanabhan S; Bots ML; Grobbee DE; Froguel P; Thuillier D; Balkau B; Bonnefond A; Cariou B; Smart M; Bao Y; Kumari M; Mahajan A; Ridker PM; Chasman DI; Reiner AP; Lange LA; Ritchie MD; Asselbergs FW; Casas JP; Keating BJ; Preiss D; Hingorani AD; ; Sattar N
Lancet Diabetes Endocrinol; 2017 Feb; 5(2):97-105. PubMed ID: 27908689
[TBL] [Abstract][Full Text] [Related]
6. Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
De Marchis GM; Dittrich TD; Malik R; Zietz AV; Kriemler LF; Ference BA; Dichgans M; Georgakis MK
Atherosclerosis; 2022 Nov; 361():41-46. PubMed ID: 36244797
[TBL] [Abstract][Full Text] [Related]
7. Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
Lotta LA; Stewart ID; Sharp SJ; Day FR; Burgess S; Luan J; Bowker N; Cai L; Li C; Wittemans LBL; Kerrison ND; Khaw KT; McCarthy MI; O'Rahilly S; Scott RA; Savage DB; Perry JRB; Langenberg C; Wareham NJ
JAMA Cardiol; 2018 Oct; 3(10):957-966. PubMed ID: 30326043
[TBL] [Abstract][Full Text] [Related]
8. The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.
Cai G; Zhang B; Shi G; Weng W; Ma C; Song Y; Zhang J
Lipids Health Dis; 2015 Nov; 14():149. PubMed ID: 26576960
[TBL] [Abstract][Full Text] [Related]
9. What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.
Qiu C; Zeng P; Li X; Zhang Z; Pan B; Peng ZYF; Li Y; Ma Y; Leng Y; Chen R
Lipids Health Dis; 2017 Jun; 16(1):111. PubMed ID: 28606094
[TBL] [Abstract][Full Text] [Related]
10.
Kent ST; Rosenson RS; Avery CL; Chen YI; Correa A; Cummings SR; Cupples LA; Cushman M; Evans DS; Gudnason V; Harris TB; Howard G; Irvin MR; Judd SE; Jukema JW; Lange L; Levitan EB; Li X; Liu Y; Post WS; Postmus I; Psaty BM; Rotter JI; Safford MM; Sitlani CM; Smith AV; Stewart JD; Trompet S; Sun F; Vasan RS; Woolley JM; Whitsel EA; Wiggins KL; Wilson JG; Muntner P
Circ Cardiovasc Genet; 2017 Aug; 10(4):e001632. PubMed ID: 28768753
[TBL] [Abstract][Full Text] [Related]
11. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
[TBL] [Abstract][Full Text] [Related]
12. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9.
Schmidt AF; Holmes MV; Preiss D; Swerdlow DI; Denaxas S; Fatemifar G; Faraway R; Finan C; Valentine D; Fairhurst-Hunter Z; Hartwig FP; Horta BL; Hypponen E; Power C; Moldovan M; van Iperen E; Hovingh K; Demuth I; Norman K; Steinhagen-Thiessen E; Demuth J; Bertram L; Lill CM; Coassin S; Willeit J; Kiechl S; Willeit K; Mason D; Wright J; Morris R; Wanamethee G; Whincup P; Ben-Shlomo Y; McLachlan S; Price JF; Kivimaki M; Welch C; Sanchez-Galvez A; Marques-Vidal P; Nicolaides A; Panayiotou AG; Onland-Moret NC; van der Schouw YT; Matullo G; Fiorito G; Guarrera S; Sacerdote C; Wareham NJ; Langenberg C; Scott RA; Luan J; Bobak M; Malyutina S; Pająk A; Kubinova R; Tamosiunas A; Pikhart H; Grarup N; Pedersen O; Hansen T; Linneberg A; Jess T; Cooper J; Humphries SE; Brilliant M; Kitchner T; Hakonarson H; Carrell DS; McCarty CA; Lester KH; Larson EB; Crosslin DR; de Andrade M; Roden DM; Denny JC; Carty C; Hancock S; Attia J; Holliday E; Scott R; Schofield P; O'Donnell M; Yusuf S; Chong M; Pare G; van der Harst P; Said MA; Eppinga RN; Verweij N; Snieder H; ; Christen T; Mook-Kanamori DO; ; Gustafsson S; Lind L; Ingelsson E; Pazoki R; Franco O; Hofman A; Uitterlinden A; Dehghan A; Teumer A; Baumeister S; Dörr M; Lerch MM; Völker U; Völzke H; Ward J; Pell JP; Meade T; Christophersen IE; Maitland-van der Zee AH; Baranova EV; Young R; Ford I; Campbell A; Padmanabhan S; Bots ML; Grobbee DE; Froguel P; Thuillier D; Roussel R; Bonnefond A; Cariou B; Smart M; Bao Y; Kumari M; Mahajan A; Hopewell JC; Seshadri S; ; Dale C; Costa RPE; Ridker PM; Chasman DI; Reiner AP; Ritchie MD; Lange LA; Cornish AJ; Dobbins SE; Hemminki K; Kinnersley B; Sanson M; Labreche K; Simon M; Bondy M; Law P; Speedy H; Allan J; Li N; Went M; Weinhold N; Morgan G; Sonneveld P; Nilsson B; Goldschmidt H; Sud A; Engert A; Hansson M; Hemingway H; Asselbergs FW; Patel RS; Keating BJ; Sattar N; Houlston R; Casas JP; Hingorani AD
BMC Cardiovasc Disord; 2019 Oct; 19(1):240. PubMed ID: 31664920
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Phenome-Wide Association Study of
Rao AS; Lindholm D; Rivas MA; Knowles JW; Montgomery SB; Ingelsson E
Circ Genom Precis Med; 2018 Jul; 11(7):e002162. PubMed ID: 29997226
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
Hopewell JC; Malik R; Valdés-Márquez E; Worrall BB; Collins R;
Eur Heart J; 2018 Feb; 39(5):354-359. PubMed ID: 29020353
[TBL] [Abstract][Full Text] [Related]
15. Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.
Pott J; Schlegel V; Teren A; Horn K; Kirsten H; Bluecher C; Kratzsch J; Loeffler M; Thiery J; Burkhardt R; Scholz M
Circ Genom Precis Med; 2018 May; 11(5):e001992. PubMed ID: 29748315
[TBL] [Abstract][Full Text] [Related]
16. Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality.
Benn M; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2019 Jun; 73(24):3102-3114. PubMed ID: 31221259
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors.
Gai MT; Adi D; Chen XC; Liu F; Xie X; Yang YN; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Sci Rep; 2021 Jun; 11(1):11450. PubMed ID: 34075144
[TBL] [Abstract][Full Text] [Related]
18. Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population.
Guella I; Asselta R; Ardissino D; Merlini PA; Peyvandi F; Kathiresan S; Mannucci PM; Tubaro M; Duga S
J Lipid Res; 2010 Nov; 51(11):3342-9. PubMed ID: 20699424
[TBL] [Abstract][Full Text] [Related]
19. Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations.
Kheirkhah A; Schachtl-Riess JF; Lamina C; Di Maio S; Koller A; Schönherr S; Coassin S; Forer L; Sekula P; Gieger C; Peters A; Köttgen A; Eckardt KU; Kronenberg F
Atherosclerosis; 2023 Dec; 386():117384. PubMed ID: 37989062
[TBL] [Abstract][Full Text] [Related]
20.
Mohamed SH; Hassaan MMM; Ibrahim BA; Sabbah NA
Genet Test Mol Biomarkers; 2021 Sep; 25(9):615-623. PubMed ID: 34550777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
